Cumulative prognostic value ofp53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy
- 22 December 1999
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 84 (6) , 573-579
- https://doi.org/10.1002/(sici)1097-0215(19991222)84:6<573::aid-ijc6>3.0.co;2-r
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control studyBritish Journal of Cancer, 1998
- TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancerOncogene, 1998
- Prognostic Significance of BCL-2 Expression in Localized Squamous Cell Carcinoma of the Head and NeckAnnals of Otology, Rhinology & Laryngology, 1997
- Immunohistochemical vs Molecular Biology Methods:Complementary Techniques for Effective Screening of p53 Alterations in Head and Neck CancerAmerican Journal of Clinical Pathology, 1997
- p53 Mutation and Locoregional Treatment Failure in Head and Neck Squamous Cell CarcinomaJNCI Journal of the National Cancer Institute, 1996
- Bcl-2 Overexpression and Smoking History in Head and Neck CancerJNCI Journal of the National Cancer Institute, 1995
- Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 1995
- Cancer statistics, 1992CA: A Cancer Journal for Clinicians, 1992
- An Alu polymorphism intragenic to the TP53 geneNucleic Acids Research, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958